Company Name | Arbutus Biopharma |
---|---|
Website | www.arbutusbio.com |
Snippet | Mar 03, 2022 · About Arbutus Biopharma. Arbutus Biopharma Corporation (NASDAQ: ABUS) is a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases.The Company’s current focus areas include Hepatitis B virus (HBV), SARS-CoV-2, and other coronaviruses. |
Type | Public |
Founded | 2007 |
Website | http://arbutusbio.com/ |
Industry | Biotechnology |
Products | HBV Therapies, ARB-1467, ARB-1740, AB-423 |
Traded as | NASDAQ: ABUSRussell 2000 Component |
Headquarters | Vancouver, British Columbia, Canada |
Arbutus Biopharma is part of the Canada company list
Arbutus Biopharma is part of the Biotechnology company list
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us